Race Oncology Ltd (RAC) — Cash Flow-to-Debt Ratio
Race Oncology Ltd (RAC) has a Cash Flow-to-Debt Ratio of -1.83x as of December 2025, meaning its operating cash flow of AU$-2.19 Million could theoretically repay -2% of its total liabilities (AU$1.20 Million) in one year. See Race Oncology Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Race Oncology Ltd Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Race Oncology Ltd across 16 annual periods. Also explore RAC shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Race Oncology Ltd (2011–2025)
Year-by-year debt coverage analysis for Race Oncology Ltd. For market capitalisation and broader financial context, see how much is Race Oncology Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.09x | AU$-4.57 Million | AU$1.48 Million | ▲ +37.9% |
| 2024 | -4.98x | AU$-9.55 Million | AU$1.92 Million | ▲ +46.1% |
| 2023 | -9.25x | AU$-10.65 Million | AU$1.15 Million | ▼ -109.5% |
| 2022 | -4.42x | AU$-6.26 Million | AU$1.42 Million | ▲ +50.8% |
| 2021 | -8.98x | AU$-4.70 Million | AU$523.11K | ▲ +11.2% |
| 2020 | -10.11x | AU$-2.46 Million | AU$243.65K | ▲ +27.4% |
| 2019 | -13.92x | AU$-2.67 Million | AU$192.12K | ▼ -11.4% |
| 2018 | -12.49x | AU$-3.87 Million | AU$309.71K | ▼ -84.2% |
| 2017 | -6.78x | AU$-2.47 Million | AU$363.57K | ▼ -767.9% |
| 2016 | -0.78x | AU$-306.06K | AU$391.62K | ▲ +10.5% |
| 2015 | -0.87x | AU$-103.69K | AU$118.78K | ▼ -191.4% |
| 2014 | -0.30x | AU$-39.56K | AU$132.05K | ▼ -1642.5% |
| 2013 | 0.02x | AU$3.71 Million | AU$191.01 Million | ▲ +112.1% |
| 2013 | -0.16x | AU$-1.90K | AU$11.85K | ▼ -894.7% |
| 2012 | 0.02x | AU$6.68 Million | AU$331.51 Million | ▼ -53.8% |
| 2011 | 0.04x | AU$11.92 Million | AU$273.20 Million | — |